In vitro potentiation of urokinase-activated lysis of human fibrin clots.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001777:Blood Coagulation; D004357:Drug Synergism; D005337:Fibrin; D005340:Fibrinogen; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005182:Flavin-Adenine Dinucleotide / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007457:Iodine Radioisotopes; D011685:Purine Nucleotides / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D011742:Pyrimidine Nucleotides / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D013917:Thrombin / Q000378:metabolism; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology*
D005343:Fibrinolytic Agents; D007457:Iodine Radioisotopes; D011685:Purine Nucleotides; D011687:Purines; D011742:Pyrimidine Nucleotides; D011743:Pyrimidines; D005182:Flavin-Adenine Dinucleotide; D000244:Adenosine Diphosphate; D005337:Fibrin; D005340:Fibrinogen; D013917:Thrombin; D014568:Urokinase-Type Plasminogen Activator